Please assess the completion status of the following clinical trial:

Trial Title: Topical Antibiotic Irrigation (Gentamicin) in Prophylaxis of Midfacial Fracture Surgical Wounds

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* patients who are planned for open reduction internal fixation of midfacial fractures as part of standard of care~* patients who are admitted to Memorial Hermann hospital at Texas Medical Center~* able to sign their own consent~Exclusion Criteria:~* infected surgical sites~* allergies to bacitracin

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- topical irrigation with the antibiotic plus intravenous (IV) prophylactic antibiotic (Type: EXPERIMENTAL): Fractures will be topically irrigated with the topical antibiotic gentamicin (80mg diluted in 1L 0.9% normal saline) prior to closure.~\[previously, this arm involve topical irrigation with bacitracin topical antibiotic (50,000 units), but in April of 2020 the study was modified to use gentamycin rather than bacitracin, after the FDA warning of the toxic side effects of bacitracin and because the hospital where the study was conducted removed bacitracin from its formulary.\]
- topical irrigation with sterile normal saline (NS) plus intravenous (IV) prophylactic antibiotic (Type: ACTIVE_COMPARATOR): Fractures will be irrigated with sterile normal saline prior to closure. All groups with receive standard parenteral (IV) prophylactic antibiotic.

Based on this trial design, predict the completion outcome and termination type (if applicable).